{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:12:00Z","timestamp":1775081520796,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jneuroim.2004.10.007","type":"journal-article","created":{"date-parts":[[2005,1,6]],"date-time":"2005-01-06T07:15:12Z","timestamp":1104995712000},"page":"196-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Involvement of p38 MAPK signaling pathway in IFN-\u03b3 and HTLV-I expression in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis"],"prefix":"10.1016","volume":"159","author":[{"given":"Naomi","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nishiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsufumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2004.10.007_bib1","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/eji.1830210815","article-title":"The human interferon-gamma gene contains an inducible promoter that can be transactivated by tax I and II","volume":"21","author":"Brown","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(95)00357-F","article-title":"SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1","volume":"364","author":"Cuenda","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","article-title":"MAP kinases in the immune response","volume":"20","author":"Dong","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib4","doi-asserted-by":"crossref","first-page":"21225","DOI":"10.1016\/S0021-9258(19)36914-5","article-title":"Transactivation by the human T-cell leukemia virus tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB)","volume":"268","author":"Franklin","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/368379","article-title":"Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis and asymptomatic HTLV-I carriers","volume":"187","author":"Furukawa","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-510X(90)90060-Z","article-title":"Pathology of chronic myelopathy associated with HTLV-I infection (HAM\/TSP)","volume":"96","author":"Iwasaki","year":"1990","journal-title":"J. Neurol. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2004.10.007_bib7","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/344269","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease","volume":"186","author":"Jacobson","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib8","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy","volume":"96","author":"Jeffery","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","article-title":"Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells","volume":"294","author":"Miyoshi","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2004.10.007_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.18.1.451","article-title":"Signaling and transcription in T helper development","volume":"18","author":"Murphy","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archneur.1989.00520370037015","article-title":"Characterization of HTLV-I in a T-cell line established from a patient with myelopathy","volume":"46","author":"Nakamura","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1054\/mehy.1999.0949","article-title":"Importance of immune deviation toward Th1 in the early immunopathogenesis of human T-lymphotropic virus type I-associated myelopathy","volume":"54","author":"Nakamura","year":"2000","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jneuroim.2004.10.007_bib13","series-title":"Human Retrovirology: HTLV","first-page":"191","article-title":"Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP","author":"Osame","year":"1990"},{"key":"10.1016\/j.jneuroim.2004.10.007_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13550280260422668","article-title":"Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP)","volume":"8","author":"Osame","year":"2002","journal-title":"J. Neurovirology"},{"key":"10.1016\/j.jneuroim.2004.10.007_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"i","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2004.10.007_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1034\/j.1600-065X.2003.00019.x","article-title":"JNK and p38 MAP kinases in CD4+ and CD8+ T cells","volume":"192","author":"Rinc\u00f3n","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.iy.12.040194.003223","article-title":"Acquisition of a lymphokine-producing phenotype by CD4+ T-cells","volume":"12","author":"Seder","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating TH1 immune responses","volume":"21","author":"Szabo","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib19","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1002\/j.1460-2075.1996.tb00840.x","article-title":"FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2","volume":"15","author":"Tan","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/viro.1996.0205","article-title":"Sequence requirements of ATF-2 and CREB binding to the human T-cell leukemia virus type 1 LTR R region","volume":"218","author":"Xu","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.jneuroim.2004.10.007_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10428199609093442","article-title":"Features of the cytokines secreted by adult T cell leukemia (ATL) cells","volume":"21","author":"Yamada","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jneuroim.2004.10.007_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/84264","article-title":"IL-18-stimulated GADD45\u03b2 required in cytokine-induced, but not TCR-induced, IFN-\u03b3 production","volume":"2","author":"Yang","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","article-title":"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control","volume":"19","author":"Yoshida","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.007_bib24","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4049\/jimmunol.165.3.1374","article-title":"The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-\u03b3 expression","volume":"165","author":"Zhang","year":"2000","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804003704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804003704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:01:43Z","timestamp":1759046503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572804003704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0165572804003704"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.10.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of p38 MAPK signaling pathway in IFN-\u03b3 and HTLV-I expression in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}